Societal CDMO inks contracts with existing customers
gorodenkoff
- Societal CDMO (NASDAQ:SCTL) said it signed work order extensions with multiple existing customers for several contract development and manufacturing organization (CDMO) services.
- The work expansions agreements include: manufacturing additional engineering batch of an antibiotic capsule formulation to treat Staphylococcus aureus infections; analytical method transfer, evaluation, and validation for an investigational therapy for attention-deficit/hyperactivity disorder (ADHD).
- In addition, executing a stability protocol and compatibility study for an investigational cancer drug; clinical trial services focused on product encapsulation, packaging, and labeling for an investigational therapy for depression.